| 000 | 00960 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250514100246.0 | ||
| 264 | 0 | _c20020501 | |
| 008 | 200205s 0 0 eng d | ||
| 022 | _a0009-7322 | ||
| 024 | 7 |
_a10.1161/01.cir.13.5.664 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHOLLANDER, W | |
| 245 | 0 | 0 |
_aThe effects of intravenous apresoline (hydralazine) on cardiovascular and renal function in patients with and without congestive heart failure. _h[electronic resource] |
| 260 |
_bCirculation _cMay 1956 |
||
| 300 |
_a664-74 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aHeart Failure _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydralazine _xtherapeutic use |
| 650 | 0 | 4 |
_aHypertension _xetiology |
| 700 | 1 | _aJUDSON, W E | |
| 700 | 1 | _aWILKINS, R W | |
| 773 | 0 |
_tCirculation _gvol. 13 _gno. 5 _gp. 664-74 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.cir.13.5.664 _zAvailable from publisher's website |
| 999 |
_c13123389 _d13123389 |
||